期刊文献+

糖尿病肾病患者血清NGAL和APN的改变及其临床意义 被引量:5

下载PDF
导出
摘要 目的:探讨糖尿病肾病(DN)患者血清中性粒细胞明胶酶相关载脂蛋白(NGAL)、脂联素(APN)的改变及其临床意义。方法选择2型糖尿病(T2DM)患者71例,根据尿微量白蛋白/肌酐比值(ACR)分为3组,正常白蛋白尿(NA)组27例、微量白蛋白尿(MA)组23例、临床白蛋白尿(CA)组21例,同期选取非肾病患者25例作为对照组。应用ELISA法检测患者血清NGAL(sNGAL)水平和血清APN(sAPN)水平,分析血清NGAL及APN水平与尿微量白蛋白/肌酐比值(ACR)和肾小球滤过率(GFR)之间的相关关系。结果(1)随着ACR水平的升高,肾功能下降,血清NGAL、APN水平逐渐升高。NA组、MA组和CA组的血清NGAL均较对照组升高,差异均有统计学意义(P均〈0.05)。MA组较NA组的血清NGAL水平升高,但差异无统计学意义(P〉0.05)。NC组、NA组、MA组、CA组、各组间血清APN水平逐渐升高,差异均有统计学意义(P均〈0.05)。(2)糖尿病患者血清NGAL与ACR呈正相关性(r=0.854,P〈0.01),血清APN与ACR亦呈正相关性(r=0.828, P〈0.01)。血清NGAL与GFR呈负相关性(r=-0.751,P〈0.01),血清APN与GFR亦呈负相关性(r=-0.816,P〈0.01)。结论糖尿病患者血清NGAL和血清APN可能参与了DN的发生与发展,有望成为DN肾损害的预测指标,用于临床监测。 Objective To explore the changes of serum NGAL and APN in patients with diabetic nephropathy and their clinical significance. Methods seventy-one type 2 diabetic patients were divided,according to albuminuria to creatinine ratio(ACR)into groups of NA(normal albuminuria n=27),MA(micro albuminuria n=23),CA(clinical albuminuria n=21),and another 25 patients without nephropathy were chosen as control group.NGAL and APN levels were detected by ELISA.The relationship of NGAL and APN with albuminuria to creatinine ratio(ACR)and glomerular filtration rate(GFR)were analyzed. Results NGAL and APN levels increased with the increase of ACR and renal function decline in each group.The NGAL levels of NA/MA/CA groups were significantly higher than the normal control groups(all P〈0.05).The NGAL level of the MA group was not significantly higher than the NA group (P〉0.05).The serum APN levels increased with the increase of ACR in each group(all P〈0.05). The serum NGAL and APN levels in patients with diabetic nephropathy were positively correlated with ACR(r=0.854,0.828,P〈0.01),and were negatively correlated with GFR(r=-0.751,-0.816,P〈0.01). Conclusion NGAL and APN may play an important role in the occurrence and development of DN. Serum NGAL and APN might be predictors of the severity of DN and is expected to be used in clinical monitoring.
出处 《浙江临床医学》 2014年第5期673-675,共3页 Zhejiang Clinical Medical Journal
基金 国家自然科学基金(81270895)广东省科技计划项目(20118061200034)广东省科技计划项目(20118061300020)
关键词 中性粒细胞明胶酶相关载脂蛋白 脂联素 糖尿病肾病 Neutrophil gelatinase-associated lipocalin Adiponectin Diabetic nephropathy
  • 相关文献

参考文献12

  • 1American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care,2013 Jan,36 Suppl 1:S11-66.
  • 2InternationalDiabetes Federation.Global Guideline for Type 2Diabetes.OL 2012:87-91.
  • 3Perkins BA,Ficociello LH,Roshan B,et al.In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int,2010 Jan,77(1):57-64.
  • 4Perkins BA,FicocieUo LH,Ostrander BE,et al.Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007 Apr,18(4):1353-1361.
  • 5Bolignano D,Donato V,Coppolino G,et al. Neutrophil gelatinase- associated lipocalin(NGAL)as a marker of kidney damage. AmJ Kidney Dis,2008,52(3):595-605.
  • 6Koshimura J,Fujita H,Narita T,et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy..Biochem Biophys Res Commun,2004,316(1):165-169.
  • 7熊晓清,冉建民,刘薇,郭顺华,张人漪,劳干诚.2型糖尿病合并糖尿病肾病脂联素水平变化及与血管内皮功能的关系[J].中国动脉硬化杂志,2012,20(3):247-251. 被引量:26
  • 8Beaglehole R,Bonita R,Horton R,et aL. Priority actions for the non- communicable disease crisis. Lancet,2011,377(9775):1438-1447.
  • 9Poniatowski B,Malyszko J,Bachorzewska-Gajewska H,et al.Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.Kidney Blood Press Res,2009,32(2):77-80.
  • 10童俊容,何凤,罗正茂,张虹,王妍春,黄远航,王寅,张建林.血清NGAL和Cystatin C对糖尿病肾病早期诊断的意义研究[J].中国全科医学,2010,13(8):810-812. 被引量:46

二级参考文献24

  • 1Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage [ J]. Am J Kidney Dis, 2008, 52 (3): 595-605.
  • 2Donadio C, Luehesi A. Serum eystatin as a marker of glomerular filtration rate [J]. Am J Kidney Dis, 2001, 37 (2) : 448 -451.
  • 3Devarajan P. Emerging biomarkers of acutekidney injury [J]. Contrib Nephrol, 2007, 156:203 -212.
  • 4Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase - associated lipocalin as a marker of renal function in childrenwith chronic kidney disease[J].Pediatr Nephrol, 2007, 22:101 -108.
  • 5Mori K, Lee HT, Rapoport D, et al. Endoeytie delivery of lipoealin - siderophore - iron complex rescues the kidney from isehemia - reperfusion injury [J]. J Clin Invest, 2005, 115 (3) : 610 -621.
  • 6Mishra J, Dent C, Tarabishi R, et al. Neutrophilgelatinase - associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005, 365:1231-1238.
  • 7Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate [ J]. Clinical Chemistry, 2002, 48 (12) : 699 - 707.
  • 8Risch L, Huber AR. Assessing the diagnostic accuracy of eystatin C as a marker of impaired glomerular filtration rate [ J ]. Am J Kidney Dis, 2002, 39:661-662.
  • 9Hotta K,Funahashi T,Arita Y,et a1.Plasma concentra-tions of a novel,adipose-specific protein adiponectin,in type2diabetic patients[J].Arterioscler Thromb Vasc Biol,2000,20:1595-599.
  • 10Kawano T,Saito T,Yasu T,et al.Close association of hy-poadiponectinemia with arteriosclerosis obliterans and is-chemic heart disease[J].Metabolism,2005,54:653-656.

共引文献69

同被引文献44

  • 1屈丹,邢桂红,哈长愉,周红,任俊敬.2008至2009年本溪市中心城区2型糖尿病患者视网膜病变患病率及相关因素调查[J].中华糖尿病杂志,2009,1(5). 被引量:6
  • 2Hovind P, Rossing P, Johnson R J, et al. Serum uric acid as a newpI- ayer in the deveIopment of diabeticn ephropathy [ J ]. J Ren Nutr, 2011,21 ( 1 ) :124-127.
  • 3Alrawahi AH, Rizvi SG, A1-Riyami D, et al. Prevalence and risk fac- tors of diabetic nephropathy in omani type 2 diabetics in Alda- khiliyab region[J]. Oman Med J,2012,27(3) :212-216.
  • 4Salgado PP, Silva IN, Vieira EC, et al. Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes[ J]. J Pediatr En- docrinol Metab,2010,23(12) :1311-1320.
  • 5Zheng F, LU W, Jia C, et al. Relationships between glucose excur- sion and the activation of oxidative stress in patients with newly di-agnosed type 2 diabetes or impaired glucose regulation [ J ]. Endo- crine, 2010,37 ( 1 ) :201-208.
  • 6王文霞,贾伟平,包玉倩,李青,陆惠娟,项坤三.肾小球滤过率评价糖尿病患者肾功能的意义及方法学比较[J].中华医学杂志,2007,87(48):3385-3388. 被引量:29
  • 7Cano NJ, Miolane-Debouit M, Leger J, et al. Assessment of body protein: energy status in chronic kidney diseas~ Semin Nephrol, 2009,29:59-66.
  • 8Beaglehole R, Bonita R, Horton R, et al. Priority actions for the noncommunicable disease crisis. Lancet, 2011,377 : 1438-1447.
  • 9YokoyamaH, Sone H, Oishi M, et al. Prevalenee of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDMIS). Nephrol Dial Transplant, 2009,24 : 1212-1219.
  • 10Cheng YH, Zhu P, Yang J, et al. Ischaemic preconditioning- regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovas- cular Research, 2010,87 : 431-439.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部